RXN
Get informed when a big investor buys or sells
+ FollowUndervalued by 7.1% based on the discounted cash flow analysis.
| Market cap | $11.44 Billion |
|---|---|
| Enterprise Value | $11.67 Billion |
| Dividend Yield | $11.57 (0.54%) |
| Earnings per Share | $1.14 |
| Beta | 1.38 |
| Outstanding Shares | 167,696,000 |
| P/E Ratio | 51.06 |
|---|---|
| PEG | 145.51 |
| Price to Sales | 6.5 |
| Price to Book Ratio | 7.22 |
| Enterprise Value to Revenue | 6.88 |
| Enterprise Value to EBIT | 38.11 |
| Enterprise Value to Net Income | 54 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.33 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Active Core International Equity ETF is an exchange traded fund launched and managed by T. Rowe Price Associates, Inc. The fund is co-managed by T. Rowe Price International Ltd. I...